SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-023021
Filing Date
2023-08-10
Accepted
2023-08-10 16:01:57
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20230515_10q.htm   iXBRL 10-Q 713034
2 EXHIBIT 31.1 ex_521676.htm EX-31.1 13420
3 EXHIBIT 31.2 ex_521677.htm EX-31.2 13253
4 EXHIBIT 32.1 ex_521678.htm EX-32.1 6694
5 EXHIBIT 32.2 ex_521679.htm EX-32.2 6773
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-23-023021.txt   3576946

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230630.xsd EX-101.SCH 35678
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20230630_cal.xml EX-101.CAL 26743
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230630_def.xml EX-101.DEF 228980
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230630_lab.xml EX-101.LAB 209884
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230630_pre.xml EX-101.PRE 245659
43 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230515_10q_htm.xml XML 470706
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 231159152
SIC: 2834 Pharmaceutical Preparations